Molecular and cellular determinants of immunity to Histoplasma capsulatum

Research in Immunology

Volumn 149, Issue 4-5, 1998, Pages 397-406

  Deepe Jr , G S ^a   Seder, R A ^b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

HISTOPLASMA CAPSULATUM; HISTOPLASMOSIS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNITY; INFLAMMATION; MACROPHAGE; MYCELIUM; NATURAL KILLER CELL; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; YEAST;

EID: 0032078651     PISSN: 09232494     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0923-2494(98)80763-3     Document Type: Article

References (77)

1. + T-cell clone. Infect. Immun., 61, 714-718.
2. Allendoerfer, R. & Deepe, G.S., Jr. (1996), Intrapulmonary response to Histoplasma capsulatum in gamma Interferon knockout mice. Infect. Immun., 65, 2564-2569.
3. Allendoerfer, R., Maresca, B. & Deepe, G.S., Jr. (1996), Cellular immune response to recombinant heat shock protein 70 from Histoplasma capsulatum. Infect. Immun., 64, 4123-4128.
4. Allendoerfer, R., Boivin, G.P. & Deepe, G.S., Jr. (1997), Modulation of immune responses in murine pulmonary histoplasmosis. J. Infect. Dis., 175, 905-914.
5. Amiri, P., Locksley, R.M., Parslow, T.G., Sadick, M., Rector, E., Ritter, D. & McKerrow, J.H. (1992), Tumor necrosis factor-α restores granulomas and induces parasite egg-laying in schistosome-infected SCID mice. Nature, 356, 604-607.
6. Asano, M., Nakane, A. & Minagawa, T. (1993), Endogenous gamma interferon is essential in granuloma formation induced by glycolipid-containing mycolic acid in mice. Infect. Immun., 61, 2872-2878.
7. Baughman, R.P., Kim, C.K, Vinegar, A., Hendricks, D.E., Schmidt, D.J. & Bullock, W.E. (1986), The pathogenesis of experimental pulmonary histoplasmosis. Correlative studies of histopathology, bronchoalveolar lavage, and respiratory function. Am. Rev. Respir. Dis., 134, 771-776.
8. Bullock, W.E. & Wright, S.D. (1987), Role of adherence-promoting receptors, CR3, LFA-1, and p 150, 95, in binding of Histoplasma capsulatum by human macrophages. J. Exp. Med., 165, 195-210.
9. Brummer, E., Kurita, N., Yoshida, S., Nishimura, K. & Miyaji, M. (1991), Fungistatic activity of human neutrophils against Histoplasma capsulatum: correlation with phagocytosis. J. Infect. Dis., 164, 158-162.
10. Cain, J.A. & Deepe, G.S., Jr. (1998), Evolution of the primary immune response to Histoplasma capsulatum in murine lung. Infect. Immun. (in press).
11. Chaturverdi, S., Frame, P. & Newman, S.L. (1995), Macrophages from human immunodeficiency virus-positive persons are defective in host defense against Histoplasma capsulatum. J. Infect. Dis., 171, 320-327.
12. Chaturverdi, S. & Newman, S.L. (1997), Modulation of the effector function of human macrophages for Histoplasma capsulatum by HTV-1. Role of the envelope glycoprotein 120. J. Clin. Invest., 100, 1465-1474.
13. Couto, M., Liu, L., Lehrer, R.I. & Ganz, T. (1994), Inhibition of intracellular Histoplasma capsulatum replication by murine macrophages that produce human defensin. Infect. Immun., 62, 2375-2378.
14. Czuprynski, C.J., Brown, J.F., Maroushek, N., Wagner, R.D. & Steinberg, H. (1994), Administration of antigranulocyte mAb RB6-8C5 impairs the resistance of mice to Listeria monocytogenes infection. J. Immunol., 152, 1836-1846.
15. Deepe, G.S., Jr., Smith, J.G., Sonnenfeld, G., Denman, D. & Bullock, W.E. (1986), Development and characterization of Histoplasma capsulatum-reactive murine T-cell clones. Infect. Immun., 54, 714-722.
16. Deepe, G.S., Jr. (1988), Protective immunity in murine histoplasmosis: functional comparison of adoptively transferred T-cell clones and splenic T cells. Infect. Immun., 56, 2350-2355.
17. Deepe, G.S., Jr. & Bullock, W.E. (1992), Histoplasmosis: a granulomatous inflammatory response, in "Inflammation: Basic Principles and Clinical Correlates" 2nd ed. (J.I. Gallin, I.M. Goldstein & R. Snyderman) (pp. 943-948). Raven Press, New York.
18. + T cells in host resistance to systemic infection with Histoplasma capsulatum in mice. J. Immunol., 152, 3491-3500.
19. Deepe, G.S., Jr. & Durose, G.G. (1995), Immunobiological activity of recombinant H antigen from Histoplasma capsulation. Infect. Immun., 63, 3151-3157.
20. Deepe, G.S., Gibbons, R. Brunner, G.D. & Gomez, F.J. (1996), A protective domain of heat-shock protein 60 from Histoplasma capsulatum. J. Infect. Dis., 174, 828-834.
21. Eisenhauer, P.B. & Lehrer, R.I. (1992), Mouse neutrophils lack defensins. Infect. Immun., 60, 3446-3447.
22. Eissenberg, L.G. & Goldman, W.E. (1987), Histoplasma capsulatum fails to trigger release of superoxide from macrophages. Infect. Immun., 55, 29-34.
23. Eissenberg, L.G., Schlesinger, P.H. & Goldman, W.E. (1988), Phagosome-lysosome fusion in P388D1 macrophages infected with Histoplasma capsulatum. J. Leukocy. Biol., 43, 483-491.
24. Eissenberg, L.G., Goldman, W.E. & Schlesinger, P.H. (1993), Histoplasma capsulatum modulates acidification of phagolysosomes. J. Exp. Med., 177, 1605-1611.
25. Feit, C. & Tewari, R.P. (1974), Immunogenicity of ribosomal preparations from yeast cells of Histoplasma capsulatum. Infect. Immun., 10, 1091-1097.
26. Feng, H.M., Popov, V.L. & Walker, D.H. (1994), Depletion of IFN-γ and TNF-α in mice with Rickettsia conorii-infected endothelium: impairment of ricketsicidal nitric oxide production resulting in fatal, overwhelming rickettsial disease. Infect. Immun., 62, 1952-1960.
27. Fleischman, J., Wu-Hsieh, B. & Howard, D.H. (1990), The intracellular fate of Histoplasma capsulatum in human macrophages is unaffected by recombinant human interferon-γ. J. Infect. Dis., 161, 143-145.
28. Garcia, J.P. & Howard, D.H. (1976), Characterization of antigens from the yeast phase of Histoplasma capsulatum. Infect. Immun., 4, 116-125.
29. Gazzinelli, R.T., Wysocka, M., Hayashi, S., Denkers, E.Y., Hieny, S., Caspar, P., Trinchieri, G. & Sher, A. (1994), Parasite-induced IL-12 stimulates early IFNγ synthesis and resistance during acute infection with Toxoplasma gondii. J. Immunol., 153, 2533-2543.
30. + T cells in host defense against Histoplasma capsulatum. Infect. Immun., 56, 1685-1691.
31. Gomez, A.M., Rhodes, J.C. & Deepe, G.S., Jr. (1991), Antigenicity and immunogenicity of an extract from the cell wall and cell membrane of Histoplasma capsulatum. Infect. Immun., 59, 330-336.
32. Gomez, F.J., Gomez, A.M. & Deepe, G.S., Jr. (1991), Protective efficacy of a 62 kilodalton antigen, HIS-62, from the cell wall and cell membrane of Histoplasma capsulatum yeast cells. Infect. Immun., 59, 4459-4464.
33. Gomez, F.J., Allendoerfer, R. & Deepe, G.S., Jr. (1995), Vaccination with recombinant heat shock protein 60 from Histoplasma capsulatum protects mice against pulmonary histoplasmosis. Infect. Immun., 63, 2587-2595.
34. Goodwin, R.A., Shapiro, J.L., Thurman, G.H., Thurman, S.S. & Des Prez, R.M. (1980), Disseminated histoplasmosis: clinical and pathological correlations. Medicine, 59, 1-31.
35. Green, S.J., Nacy, C.A., Schreiber, R.D., Granger, D.L., Crawford, R.M., Meltzer, M.S. & Fortier, A.H. (1993), Neutralization of IFN-γ and TNF-α blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect. Immun., 61, 689-698.
36. Gudmundssen, G. & Hunninghake, G.W. (1997), Interferon-gamma is necessary for the expression of hypersensitivity pneumonitis. J. Clin. Invest., 99, 2386-2390.
37. Han, Y. & Cutler, J.E. (1997), Assessment of a mouse model of neutropenia and the effect of an anti-candidiasis monoclonal antibody in these animals. J. Infect. Dis., 175, 1169-1175.
38. + T cells through IL-12 produced by Listeria-induced macrophages. Science, 260, 547-549.
39. Kindler, V., Sappino, A.P., Grau, G.E., Piguet, P.P. & Vasalli, P. (1989), The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection. Cell, 56, 731-740.
40. Lane, T.E., Wu-Hsieh, B.A. & Howard, D.H. (1992), Iron limitation and the gamma interferon-mediated antihistoplasma state of murine macrophages. Infect. Immun., 59, 2274-2278.
41. Lane, T.E., Wu-Hsieh, B.A. & Howard, D.H. (1993), Gamma interferon cooperates with lipopolysaccharide to activate mouse splenic macrophages to an antihistoplasma state. Infect. Immun., 61, 1468-1473.
42. Lane, T.E., Wu-Hsieh, B.A. & Howard, D.H. (1994a), Antihistoplasma effect of activated mouse splenic macrophages involves production of reactive nitrogen intermediates. Infect. Immun., 62, 1940-1945.
43. Lane, T.E., Otero, G.C., Wu-Hsieh, B.A. & Howard, D.H. (1994b), Expression of inducible nitric oxide synthase by stimulated macrophages correlates with their antihistoplasma activity. Infect. Immun., 62, 1478-1479.
44. Langermans, J.A.M., van der Hulst, M.E.B., Nibbering, P.H., Hiemstra, P.S., Fransen, L. & van Furth, R. (1992), IFN-γ-induced L-arginine-dependent toxoplasmastatic activity in murine peritoneal macrophages is mediated by endogenous TNF-α. J. Immunol., 148, 568-574.
45. Lloyd, A.R. & Oppenheim, J.J. (1992), Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol. Today, 13, 169-172.
46. Ma, X., Chow, J.M., Gri, G., Carra, G., Gerosa, F., Wolf, S.F., Dzialo, R. & Trinchieri, G. (1996), The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med., 183, 147-158.
47. Maresca, B. & Kobayashi, G.S. (1989), Dimorphism in Histoplasma capsulatum: a model for the study of cell differentiation in pathogenic fungi. Microbiol. Rev., 53, 186-209.
48. Medoff, G., Sacco, M., Maresca, B., Schlessinger, D., Painter, A., Kobayashi, G.S. & Carratu, L. (1986), Irreversible block of the mycelial-to-yeast phase transition of Histoplasma capsulation. Science, 231, 476-479.
49. Nacy, C.A., Meierovics, A.I., Belosevic, M. & Green, S.J. (1991), TNF-α central regulatory cytokine in the induction of macrophage antimicrobial activities. Pathobiology, 59, 182-184.
50. Newman, S.L., Bucher, C., Rhodes, J.C. & Bullock, W.E. (1990), Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J. Clin. Invest., 85, 223-230.
51. Newman, S.L. & Gootee, L. (1992), Colony-stimulating factors activate human macrophages to inhibit intracellular growth of Histoplasma capsulatum yeasts. Infect. Immun., 60, 4593-4597.
52. Newman, S.L., Gootee, L. & Gabay, J.E. (1993), Human neutrophil-mediated fungistasis against Histoplasma capsulatum. Localization of fungistatic activity to the azurophil granules. J. Clin. Invest., 92, 624-631.
53. Newman, S.L., Gootee, L., Brunner, G.D. & Deepe, G.S., Jr. (1994), Chloroquine induces human macrophage killing of Histoplasma capsulatum by limiting the availability of intracellular iron and is therapeutic in a murine model of histoplasmosis. J. Clin. Invest., 93, 1422-1429.
54. Newman, S.L., Gootee, L., Kidd, C., Ciraolo, G.M. & Morris, R. (1997), Activation of human macrophage fungistatic activity against Histoplasma capsulatum upon adherence to type 1 collagen matrices. J. Immunol., 158, 1779-1786.
55. Newman, S.L. & Kidd, C. (1997), Neutrophils are essential in host defense against Histoplasma capsulatum. Presented at the 97th General Meeting of the American Society for Microbiology, Miami Beach, Fla. Abstract F-98.
56. Patino, M.M., Williams, D.M., Ahrens, J. & Graybill, J.R. (1987), Experimental histoplasmosis in the beige mouse. J. Leukocy. Biol., 41, 228-235.
57. r congenic mouse strains. Infect. Immun., 59, 3935-3944.
58. Salvin, S.B. (1965), Constituents of the cell wall of the yeast phase of Histoplasma capsulatum. Am. Rev. Respir. Dis., 92, 119-125.
59. Saslow, S. & Schaeffer, J. (1956), Survival of Histoplasma capsulatum in experimental histoplasmosis in mice. Proc. Soc. Exp. Biol. Med., 91, 412-414.
60. Scharton-Kersten, T.M., Wynn, T.A., Denkers, E.Y., Bala, S., Grunvald, E., Hieny, S., Gazzinelli, R.T. & Sher, A. (1996), In the absence of endogenous IFN-γ, mice develop unimpaired IL-12 responses to Toxoplasma gondii while failing to control acute infection. J. Immunol., 157, 4045-4054.
61. Schnur, R.A. & Newman, S.L. (1990), The respiratory burst response to Histoplasma capsulatum by human neutrophils. Evidence for intracellular trapping of superoxide anion. J. Immunol., 144, 4765-4772.
62. Schwarz, J. (1981), "Histoplasmosis" (pp. 198-293). Praeger, New York.
63. + T cells. Annu. Rev. Immunol., 12, 635-674.
64. Smith, J.G., Magee, D.M., Williams, D.M. & Graybill, J.R. (1990). Tumor necrosis factor-α plays an important role in host defense against Histoplasma capsulatum. J. Infect. Dis., 162, 1349-1353.
65. Szalay, G., Ladel, C.H., Blum, C. & Kaufmann, S.H.E. (1996), IL-4 neutralization or TNF-α treatment ameliorate disease by an intracellular pathogen in IFN-γ receptor-deficient mice. J. Immunol., 157, 4746-4750.
66. Tripp, C.S., Gately, M.K., Hakimi, J., Ling, P. & Unanue, E. (1994), Neutralization of IL-12 decreases resistance to Listeria monocytogenes in SCID and CB-17 mice, reversal by IFN-γ. J. Immunol., 152, 1883-1887.
67. Tripp, C.S., Kanagawa, O. & Unanue, E.R. (1995), Secondary response to Listeria infection requires IFN-γ but is partially independent of IL-12. J. Immunol., 155, 3427-3432.
68. Wheat, L.J., Connolly-Stringfield, P.A., Baker, R.L., Curfman, M.F., Eads, M.E., Israel, K.S., Norris, S.A., Webb, D.H. & Zeckel, M.L. (1990), Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine, 69, 361-374.
69. Williams, D.M., Graybill, J.R. & Drutz, D.J. (1978), Histoplasma capsulatum infection in nude mice. Infect. Immun., 21, 973-977.
70. Wolf, J.E., Kerchberger, V., Kobayashi, G.S. & Little, J.R. (1987), Modulation of the macrophages oxidative burst by Histoplasma capsulatum. J. Immunol., 138, 582-586.
71. Wu-Hsieh, B. & Howard, D.H. (1984), Inhibition of growth of Histoplasma capsulatum by lymphokine-stimulated macrophages. J. Immunol., 132, 2593-2597.
72. Wu-Hsieh, B.A. & Howard, D.H. (1987), Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon. Infect. Immun., 55, 1014-1016.
73. Wu-Hsieh, B. (1989), Relative susceptibility of inbred mouse strains C57BL/6 and A/J to infection with Histoplasma capsulatum. Infect. Immun., 57, 3788-3792.
74. Wu-Hsieh, B.A., Lee, G.-S., Franco, M. & Homan, P.M. (1992), Early activation of splenic macrophages by tumor necrosis factor alpha is important in determining the outcome of experimental histoplasmosis in mice. Infect. Immun., 60, 4230-4238.
75. Zhou, P., Sieve, M.C., Bennett, J., Kwon-Chung, K.J., Tewari, R.P., Gazzinelli, R.T., Sher, A. & Seder, R.A. (1995), IL-12 prevents mortality in mice infected Histoplasma capsulatum through induction of IFNγ. J. Immunol., 155, 785-795.
76. Zhou, P., Sieve, M.C., Tewari, R.P. & Seder, R.A. (1997), Interleukin-12 modulates the protective immune response to SCID mice infected with Histoplasma capsulatum. Infect. Immun., 65, 936-942.
77. Zhou, P., Miller, G. & Seder, R.A. (1998), Factors involved in regulating primary and secondary immunity to infection with Histoplasma capsulatum: TNF-α plays a critical role in maintaining secondary immunity in the absence of IFN-γ. J. Immunol., 160, 1359-1368.